About

About UL BIO

UL BIO is developing human cell programming technology. Based in Singapore, our focus is programming adipose-derived human cells toward hematopoietic progenitor-like states - the FAT → BLOOD programme.

How we work

• Evidence-bounded claims. Public statements go only as far as the data - see Evidence & status.
• Structured records. Every run's conditions, batches and results are recorded in BLOOD OS.
• Independent verification first. Third-party replication and audit come before any product claim.

Working with us

Near term, the programme operates as a Research Use Only research platform. Commercial engagement follows a staged protocol: paid feasibility, then field-limited option, then development licence - all within RUO boundaries. Contact bd@ulbio.tech for research collaborations.

Corporate details